infertility. Female infertility
Conditions
Interventions
Intervention 1: Intervention group: In the GnRH group, Stop starts in the mid-luteal phase (previous cycle) and with the onset of menstruation on the 2nd-3rd day of the gonadotropin cycle, the dose of
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: PCO patients according to Rotterdam criteria Age 20 to 35 years Infertility > 1 year Sperm analysis is normal or has the minimum necessary criteria for ICSI AMH above 5
Exclusion criteria
Exclusion criteria: History of autoimmune diseases, coagulation disorders, uterine anomalies, chromosomal and genetic disorders, chronic renal and metabolic diseases, hypo and hyperthyroidism, history of malignancy, endometriosis, history of repeated miscarriage and repeated implantation failure Pharmaceutical reaction to ovulation stimulation drugs Lack of follicle growth suitable for puncture The patient's lack of consent to complete the treatment course Severe Oligoastenoteratospermia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of follicles above 16 mm, the degree of follicle synchrony, the number and quality of obtained oocytes (metaphase 1, 2 and GV). Timepoint: The examination will be cross-sectional on the day of oocyte puncture. Method of measurement: Questionnaire for demographic information and patient records, ultrasound to check follicles and embryology laboratory information to check the number and quality of oocytes and embryos. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number and quality of embryos. Timepoint: On the day of ovarian puncture. Method of measurement: It is determined by the embryologist three days after the puncture. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarjan Ghaemi
Tehran University of Medical Sciences
Outcome results
None listed